Abstract |
Whipple's disease is a multisystem disorder that was first reported just over 100 years ago. Only recently, the bacillus responsible for the condition was identified and subsequently cultured. However, differences of opinion remain regarding the best antibiotic regimen and duration of therapy at primary diagnosis and there is also great uncertainty about the management of disease relapse. We report a case of clinical relapse of Whipple's disease in a man who was on a prolonged therapy with trimethoprim-sulfamethoxazole. We describe his management and review the literature on the treatment of this condition, with particular reference to the recurrence of the disease.
|
Authors | G Garas, W S Cheng, R Abrugiato, G M Forbes |
Journal | Journal of gastroenterology and hepatology
(J Gastroenterol Hepatol)
Vol. 15
Issue 10
Pg. 1223-6
(Oct 2000)
ISSN: 0815-9319 [Print] Australia |
PMID | 11106107
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Anti-Bacterial Agents
- Anti-Infective Agents
- Cephalosporins
- Penicillins
- Ceftriaxone
- Trimethoprim, Sulfamethoxazole Drug Combination
- Penicillin G
- Streptomycin
- Penicillin V
|
Topics |
- Administration, Oral
- Adult
- Anti-Bacterial Agents
(administration & dosage, therapeutic use)
- Anti-Infective Agents
(administration & dosage)
- Biopsy
- Ceftriaxone
(administration & dosage, therapeutic use)
- Cephalosporins
(administration & dosage, therapeutic use)
- Duodenum
(pathology)
- Follow-Up Studies
- Humans
- Injections, Intravenous
- Intestinal Mucosa
(pathology)
- Male
- Penicillin G
(administration & dosage, therapeutic use)
- Penicillin V
(administration & dosage, therapeutic use)
- Penicillins
(administration & dosage, therapeutic use)
- Recurrence
- Streptomycin
(administration & dosage, therapeutic use)
- Time Factors
- Trimethoprim, Sulfamethoxazole Drug Combination
(administration & dosage)
- Whipple Disease
(drug therapy, pathology)
|